Clinical Trials Logo
  1. Home
  2. Liver Tumor
  3. NCT00955097

Evaluation of Intra-operative Ultrasound Contrast Enhancement in the Evaluation of Liver Tumors — Definity®  

Liver Tumors Clinical Trial

Official title:
Evaluation of Intra-operative Ultrasound Contrast Enhancement in the Evaluation of Liver Tumors

Clinical Trial Summary

The primary purpose of this study is to demonstrate the safety and effectiveness of using an intra-operative ultrasound contrast agent(Definity®) for the identification of known liver tumors.

Clinical Trial Description

The primary objective of this study is to demonstrate the safety of the use of intra-operative ultrasound contrast (Definity®) administration. The secondary objective of this study is to demonstrate the improved image quality and conspicuity of known liver tumors using contrast enhancement. ;

Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00955097
Study type Interventional
Source University of Louisville
Contact
Status Terminated
Phase Phase 1
Start date May 2008
Completion date May 2010
View Details
See also
  Status Clinical Trial Phase
Terminated NCT01197820 - Hepatic and Renal Thermography Using Magnetic Resonance Imaging N/A
Terminated NCT00942383 - Freehand Ultrasound Elasticity Imaging in Liver Surgery
Completed NCT01782573 - The Efficacy of Chlorhexidine Gluconate Pre - Disinfection Scrubbing in Preventing Surgical Site Infections for Hepatectomy Patients Phase 4
Active, not recruiting NCT03432806 - A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors
Completed NCT01403727 - Electromagnetic Tracking of Devices During Biopsy Procedures N/A
Recruiting NCT00691691 - Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors Phase 2
Recruiting NCT02184182 - Laparoscopic Microwave Ablation and Portal Vein Ligation for Staged Hepatectomy (LAPS) Phase 2
Completed NCT02162732 - Molecular-Guided Therapy for Childhood Cancer N/A
Recruiting NCT05990257 - CMRA for US-guided-MWA of Liver Tumors N/A
Completed NCT00828607 - Contrast Enhanced (CE) Ultrasound and CE Computed Tomography or CE Magnetic Resonance Imaging in Liver Masses N/A
Completed NCT00960609 - Communicating Veins Between Adjacent Hepatic Veins: an Intra-operative Ultrasound Study N/A
Completed NCT05445973 - Added Value of Contrast-enhanced Ultrasonography for Percutaneous Radiofrequency Ablation N/A
Completed NCT03171428 - Hepatectomy With or Without the Thoraco-abdominal Approach N/A
Completed NCT02509507 - Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611 Phase 1/Phase 2
Completed NCT00877136 - A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®
Terminated NCT04315883 - Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors
Completed NCT01031784 - Radioactive Holmium Microspheres for the Treatment of Liver Metastases Phase 1
Active, not recruiting NCT00845689 - Prevention of Liver Damage During Liver Surgery Phase 1/Phase 2